NIH-funded research R01 grant

Investigating how a specific protein influences obesity variation

Official title: A Trim28-ERV axis drives phenotypic variation in obesity

Funded at Van Andel Research Institute · NIH-10909000 · Data updated 2026-11-12

This study is looking at how a protein called Trim28 affects factors that can lead to obesity, helping us understand why some people gain weight differently, and it could provide helpful insights for those struggling with obesity beyond just genetics and lifestyle.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionVan Andel Research Institute
NIH-funded
Lab location1 site (Grand Rapids, United States)
Project startSeptember 1, 2023
Project endAugust 31, 2026
Funding year2024
Award (this year)$575,999
NIH project number5R01DK132216-02
Project IDNIH-10909000 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals experiencing unexplained variations in obesity that cannot be attributed to genetic or environmental factors.

Less likely to help

Patients whose obesity is clearly linked to genetic factors or environmental influences may not benefit from this research.

What this research studies

This research explores the role of the Trim28 protein in regulating non-genetic factors that contribute to obesity. By studying animal models, the researchers aim to understand how variations in the expression of certain genes, influenced by Trim28, can lead to different obesity phenotypes. The study focuses on the interaction between Trim28 and endogenous retroviruses, which may affect gene expression and metabolic outcomes. Patients may benefit from insights into the biological mechanisms behind obesity that are not solely based on genetics or environment.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for understanding and treating obesity by targeting non-genetic factors.

How similar studies have gone: Other research has shown promising results in understanding the role of epigenetics in obesity, suggesting that this approach could yield valuable insights.

Where this research is happening

  • Van Andel Research Institute
    Grand Rapids, United States
    Active

Researchers

  • Principal investigator: Pospisilik, John Andrew — Van Andel Research Institute
  • Study coordinator: Pospisilik, John Andrew

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.